Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Delivering purposeful solutions at Obesity Week 2025

    October 9, 2025 | Obesity Week 

    We’re attending Obesity Week 2025, the world’s leading event dedicated to obesity research and care, to showcase how our integrated expertise is advancing progress in obesity and cardiometabolic health.

    - PMLiVE

    Obesity Week 2025 is the premier global event dedicated to obesity research, prevention, and care – bringing together leading scientists, clinicians, and innovators to advance progress in one of the most dynamic areas of healthcare.​

    At Inizio, we’re uniting science, strategy, and creativity to deliver purposeful solutions across obesity and cardiometabolic health. Our integrated teams collaborate across the full commercialization journey to help clients navigate complexity, unlock value, and enhance outcomes at every stage of development and delivery.​

    Our experience spans the full obesity ecosystem: we’ve supported over 20 leading anti-obesity therapies, partnered on 80% of the largest GLP-1 assets, and worked across 18 specialized services to deliver smarter, connected solutions that make an impact.​

    Visit us at booth #812 to meet our experts and explore how Inizio’s integrated expertise is transforming the future of obesity and cardiometabolic care.​

    If you’d like to meet with us at Obesity Week, please get in touch.

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    A safe place to talk about Crohn’s

    Published in eyeforpharma April 2017 by Mariel Metcalfe

    Patient Assistance Programme Evaluation for Cardiovascular Conditions

    Our client had launched a self-injection treatment for cardiovascular conditions and were creating an accompanying Patient Assistance Programme (PAP) to educate patients in the use and uptake of this product.Read the case...

    What next for the treatment of Psoriasis in Europe?

    Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe.

    20 questions: Round 1

    As it's our 20th year anniversary, we invited our employees to play 20 questions - this month "What's the biggest challenge you've overcome at Research Partnership?"Watch the video: https://www.researchpartnership.com/news/2017/03/20-questions-round-1/

    Brand tracking research

    A common challenge for brand tracking is ensuring the research programme stays relevant to the brand’s current environment. In this video Quantitative Research Directors Karen Swords and Vicky McLellan outline...

    Pharma China Annual Forum 2017

    We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China.

    Healthcare Market Research in the Gulf: 3 lessons I’ve learned

    A few key considerations for conducting healthcare market research in the Gulf

    Case study: Multiple Sclerosis new medical device research

    Our client wanted to find out how best to develop an implantable delivery device technology with add-on services in the Multiple Sclerosis market. We were tasked with finding out whether such a...

    Patient Centricity: Turning Rhetoric into Reality

    Live webinar: Thursday 30th March 10:00 EDT / 15:00 BST / 16:00 CEST

    Making sense of Nutraceuticals in China

    Published in eyeforpharma February 2017 by Marc Yates